NYSE : PACS
PACS Group, Inc. — Key statistics
Healthcare · Medical Care Facilities · United States
Last price 49.68 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 7.87B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 7.57B |
| Enterprise Value | 10.81B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 158.34M |
| Shares Outstanding | 158.34M |
| Shares Change (YoY) | -2.85% |
| Shares Change (QoQ) | -0.06% |
| Owned by Insiders (%) | 68.87% |
| Owned by Institutions (%) | 31.39% |
| Float | 49.29M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 27.96 |
| Forward PE | 18.86 |
| PS Ratio | 1.36 |
| Forward PS | 1.21 |
| PB Ratio | 6.82 |
| P/TBV Ratio | 7.26 |
| P/FCF Ratio | 16.61 |
| P/OCF Ratio | 13.21 |
| PEG Ratio | 1.26 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 40.16 |
| EV / Sales | 1.95 |
| EV / EBITDA | 22.60 |
| EV / EBIT | 26.35 |
| EV / FCF | 23.72 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.91 |
| Quick Ratio | 0.84 |
| Debt / Equity | 3.05 |
| Debt / EBITDA | 3.77 |
| Debt / FCF | 7.47 |
| Interest Coverage | 13.88 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 27.92% |
| Return on Assets (ROA) | 4.60% |
| Return on Invested Capital (ROIC) | 6.67% |
| Return on Capital Employed (ROCE) | 8.92% |
| Weighted Average Cost of Capital (WACC) | 2.82% |
| Revenue Per Employee | $116,975 |
| Profits Per Employee | $5,672 |
| Employee Count | 47,455 |
| Asset Turnover | 0.99 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | 113.55M |
| Effective Tax Rate | 29.67% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | -0.08 |
| 52-Week Price Change | +284.33% |
| 50-Day Moving Average | 44.18 |
| 200-Day Moving Average | 39.71 |
| Relative Strength Index (RSI) | 57.65 |
| Average Volume (20 Days) | 814,492 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 4.33M |
| Short Previous Month | 3.74M |
| Short % of Shares Out | 2.74% |
| Short % of Float | 8.80% |
| Short Ratio (days to cover) | 5.27 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 5.55B |
| Gross Profit | 961.21M |
| Operating Income | 410.32M |
| Pretax Income | 382.68M |
| Net Income | 269.17M |
| EBITDA | 478.30M |
| EBIT | 410.32M |
| Earnings Per Share (EPS) | $1.71 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 164.45M |
| Total Debt | 3.40B |
| Net Cash | -3.24B |
| Net Cash Per Share | -$20.47 |
| Equity (Book Value) | 1.12B |
| Book Value Per Share | 7.01 |
| Working Capital | -92.70M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 573.25M |
| Capital Expenditures | -117.47M |
| Depreciation & Amortization | 67.98M |
| Net Borrowing | -155.23M |
| Free Cash Flow | 455.78M |
| FCF Per Share | $2.88 |
Margins
| Measure | Value |
|---|
| Gross Margin | 17.32% |
| Operating Margin | 7.39% |
| Pretax Margin | 6.89% |
| Profit Margin | 4.85% |
| EBITDA Margin | 8.62% |
| EBIT Margin | 7.39% |
| FCF Margin | 8.21% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.85% |
| Shareholder Yield | 2.85% |
| Earnings Yield | 3.58% |
| FCF Yield | 6.02% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $59.00 |
| Price Target Difference | 23.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 10.45% |
| EPS Growth Forecast (3Y) | 18.39% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 1.86 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |